Cardiovascular Risk in Patients With IBD
Observational · No treatment assigned · Sites not listed yet · IRCCS Policlinico S. Donato
Official record & contacts on ClinicalTrials.gov ↗
In plain English
What this trial is testing
Condition(s) listed: Ulcerative Colitis (UC), Crohn's Diseases and Cardiovascular Risk. This is an observational study: researchers collect information (for example questionnaires, samples, or scans) but the study does not assign a treatment.
Who can join
- Ages 18 and older
- Any sex
- Healthy volunteers accepted
Some of the main requirements, copied from the record:
- Established diagnosis of ulcerative colitis and Crohn's disease
There are also 1 reasons someone might not be able to join (exclusion criteria). Only the trial team can confirm whether you qualify.
What's involved
- About 300 participants are expected to take part.
- The study has 1 group.
- Start date: 2026-09 (planned).
- Main results expected around 2029-08 (estimate from the record).
- No study sites are listed yet. Check the official record for contact details.
Groups in this study
- Inflammatory Bowel Disease
Main thing being measured
- Major cardiovascular events (2 years)
In the researchers’ words
In this study the Research Hospital San Donato Policlinic ask the participation with the aim to evaluate the risk of cardiovascular complication (i.e. stroke, myocardial infarction) in patients with inflammatory bowel disease. Multiple parameters (therapy, disease activity, life style) and investigations (DNA, stool, lab tests) will be evaluate with the support of artificial intelligence methodologies to better…
This summary was written automatically from the official record using fixed templates (no AI), so it only says what the record says, and may leave things out.
Questions to ask your doctor and the trial team
- Am I likely to qualify, given my health history?
- What would I have to do, and how often would I need to visit?
- Could I get a placebo? What happens to my current treatment?
- What are the possible risks and benefits?
- Are travel or other costs covered?
- What happens after the trial ends?
Official details
| Status | Not yet recruiting |
|---|---|
| Phase | Observational |
| Study type | Observational |
| Conditions | Ulcerative Colitis (UC); Crohn's Diseases; Cardiovascular Risk |
| Lead sponsor | IRCCS Policlinico S. Donato |
| Collaborators | IRCCS Casa Sollievo della Sofferenza |
| Enrollment | 300 (estimated) |
| Start date | 2026-09 |
| Primary completion (est.) | 2029-08 |
| First posted | 2026-06-23 |
| Last updated | 2026-10-16 |
| Official title | Dissecting the Complexity of Inflammatory Bowel Disease (IBD) A Prospective Study With Focus on Cardiovascular Risk |
| ClinicalTrials.gov ID | NCT07663201 |
Interventions
- None listed
Full eligibility criteria (from the record)
Inclusion Criteria: Established diagnosis of ulcerative colitis and Crohn's disease Exclusion Criteria: Age > 18 years Not compliant with study protocol
Locations (0)
No sites listed yet. The official record has contact information.
For contacts at each site, use the official record.
Information only, not medical advice. Talk to your doctor and the trial team before making any decision about a clinical trial.